NanoViricides
NNVC
#10149
Rank
A$29.88 M
Marketcap
A$1.39
Share price
-3.50%
Change (1 day)
-29.05%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: A$29.88 Million

As of February 2026 NanoViricides has a market cap of A$29.88 Million. This makes NanoViricides the world's 10149th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026A$29.88 M-22%
2025A$38.31 M10.75%
2024A$34.59 M96.75%
2023A$17.58 M-7.14%
2022A$18.93 M-67.98%
2021A$59.13 M48.56%
2020A$39.8 M186.87%
2019A$13.87 M-29.68%
2018A$19.73 M-72.36%
2017A$71.39 M-17.36%
2016A$86.39 M-7.75%
2015A$93.66 M-50.18%
2014A$0.18 B-30.19%
2013A$0.26 B274.01%
2012A$72 M-18.96%
2011A$88.84 M-55.77%
2010A$0.20 B60.92%
2009A$0.12 B-11.4%
2008A$0.14 B165.05%
2007A$53.15 M

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of NanoViricides was reported to be:

A$29.88 Million
by Nasdaq info icon info icon
A$29.88 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
A$252.92 B 846,140.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$395.51 B 1,323,224.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$160.92 B 538,339.11%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$149.75 B 500,948.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A$2.06 B 6,805.62%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$2.34 B 7,741.52%๐Ÿ‡บ๐Ÿ‡ธ USA